CSS
VYGR icon

Cubist Systematic Strategies’s Voyager Therapeutics VYGR Stock Holding History

Cubist Systematic Strategies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$208K Buy
+44,558
New +$161K ﹤0.01% 2643
2025
Q1 		– Sell
-5,074
Closed -$28.8K – 3591
2024
Q4 		$28.8K Buy
+5,074
New +$32.7K ﹤0.01% 2823
2024
Q2 		– Sell
-94,448
Closed -$879K – 4110
2024
Q1 		$879K Buy
+94,448
New +$797K 0.01% 2264
2023
Q3 		– Sell
-18,335
Closed -$210K – 3971
2023
Q2 		$210K Sell
18,335
-77,324
-81% -$800K ﹤0.01% 2799
2023
Q1 		$738K Buy
+95,659
New +$761K ﹤0.01% 2422
2022
Q4 		– Sell
-35,693
Closed -$211K – 4631
2022
Q3 		$211K Sell
35,693
-26,851
-43% -$172K ﹤0.01% 3726
2022
Q2 		$370K Sell
62,544
-151,640
-71% -$1.02M ﹤0.01% 3291
2022
Q1 		$1.63M Buy
214,184
+193,661
+944% +$864K 0.01% 1656
2021
Q4 		$56K Buy
+20,523
New +$70K ﹤0.01% 3298
2021
Q2 		– Sell
-25,674
Closed -$121K – 3129
2021
Q1 		$121K Buy
+25,674
New +$175K ﹤0.01% 2604
2020
Q3 		– Sell
-17,531
Closed -$221K – 2664
2020
Q2 		$221K Sell
17,531
-24,932
-59% -$290K ﹤0.01% 1991
2020
Q1 		$389K Sell
42,463
-22,469
-35% -$258K 0.01% 1384
2019
Q4 		$906K Buy
64,932
+13,562
+26% +$197K 0.02% 1227
2019
Q3 		$884K Buy
+51,370
New +$1.08M 0.02% 1035
2019
Q1 		– Sell
-44,289
Closed -$416K – 2438
2018
Q4 		$416K Buy
+44,289
New +$568K 0.02% 1082
2018
Q3 		– Sell
-15,650
Closed -$306K – 2098
2018
Q2 		$306K Sell
15,650
-2,589
-14% -$51.2K 0.02% 1076
2018
Q1 		$343K Buy
+18,239
New +$394K 0.02% 1056

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cubist Systematic Strategies's VYGR Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Voyager Therapeutics (VYGR) in Q3 2025: 44,558 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #2643 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in VYGR as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in VYGR in Q1 2018 and has held it in 17 quarters since. The position peaked at $1.63M in Q1 2022. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Cubist Systematic Strategies held 44,558 shares of Voyager Therapeutics worth $208K as of Q3 2025.
  • Voyager Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Voyager Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2643 holding.
  • Cubist Systematic Strategies first reported a position in Voyager Therapeutics in Q1 2018 and has held it in 17 quarters since.
  • Cubist Systematic Strategies's Voyager Therapeutics position peaked at $1.63M in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.